Pembrolizumab combined with paclitaxel and platinum as induction therapy for locally advanced esophageal squamous cell carcinoma: a retrospective, single-center, three-arm study

BACKGROUND: Pembrolizumab has been shown to have a powerful benefit for locally advanced or metastatic esophageal cancer. The aim of present study was to evaluate the efficacy and safety of pembrolizumab combined with neoadjuvant chemotherapy for locally advanced and potentially resectable esophagea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wenbao, Huang, Yangyun, Zhu, Lihuan, Li, Wujin, Zhao, Lilan, Pan, Xiaojie, Lin, Jinlan, Guo, Tianxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830331/
https://www.ncbi.nlm.nih.gov/pubmed/36636044
http://dx.doi.org/10.21037/jgo-22-1196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830331/
https://www.ncbi.nlm.nih.gov/pubmed/36636044
http://dx.doi.org/10.21037/jgo-22-1196

Ejemplares similares